» Articles » PMID: 38398253

State-of-the-Art of Transcatheter Left Atrial Appendage Occlusion

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Feb 24
PMID 38398253
Authors
Affiliations
Soon will be listed here.
Abstract

Left atrial appendage occlusion (LAAO) is an increasingly used alternative to oral anticoagulation in patients with atrial fibrillation, especially in patients with absolute/relative contraindications to these therapies. This review will cover three main aspects of the procedure. In the fist part of the manuscript, we focus on patient selection. We describe three main categories of patients with primary indication to LAAO, namely patients with previous or at a high risk of intracerebral bleeding, patients with a history of major gastrointestinal bleeding and patients with end-stage renal disease and absolute contraindication to novel oral anticoagulants. Some other potential indications are also described. In the second part of the manuscript, we review available devices, trying to highlight different aspects and potential specific advantages. The last section overviews different ways for pre-, intra- and postprocedural imaging, in order to improve procedural safety and efficacy and ameliorate patient outcome. The characteristics of available contemporary devices and the role of imaging in procedural planning, intraprocedural guidance and follow-up are described.

Citing Articles

Usefulness of preprocedural 3-dimensional computed tomography planning in assisting one-stage pulmonary veins isolation with concomitant left atrial appendage occlusion procedure: A pilot study.

Chen K, Lin Y, Wu M, Wu Y, Feng W, Lo P Int J Cardiol Heart Vasc. 2025; 56():101594.

PMID: 39840254 PMC: 11750276. DOI: 10.1016/j.ijcha.2024.101594.

References
1.
Shatla I, El-Zein R, Kennedy K, Elkaryoni A, Ubaid A, Wimmer A . Comparison of the Safety of Left Atrial Appendage Occlusion in Patients Aged <75 Versus Those Aged ≥75 Years (from a Nationwide Cohort Sample). Am J Cardiol. 2022; 172:35-39. PMC: 10041667. DOI: 10.1016/j.amjcard.2022.02.036. View

2.
Boersma L, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B . Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2017; 14(9):1302-1308. DOI: 10.1016/j.hrthm.2017.05.038. View

3.
Luani B, Genz C, Herold J, Mitrasch A, Mitusch J, Wiemer M . Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device. BMC Cardiovasc Disord. 2019; 19(1):112. PMC: 6518765. DOI: 10.1186/s12872-019-1097-0. View

4.
Alkhouli M, Busu T, Shah K, Osman M, Alqahtani F, Raybuck B . Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. JACC Clin Electrophysiol. 2018; 4(12):1629-1637. DOI: 10.1016/j.jacep.2018.09.007. View

5.
Holmes D, Reddy V, Turi Z, Doshi S, Sievert H, Buchbinder M . Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009; 374(9689):534-42. DOI: 10.1016/S0140-6736(09)61343-X. View